Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add more filters











Database
Language
Publication year range
1.
J Vis Exp ; (79): e50146, 2013 Sep 24.
Article in English | MEDLINE | ID: mdl-24084570

ABSTRACT

In utero electroporation (IUE) is a technique which allows genetic modification of cells in the brain for investigating neuronal development. So far, the use of IUE for investigating behavior or neuropathology in the adult brain has been limited by insufficient methods for monitoring of IUE transfection success by non-invasive techniques in postnatal animals. For the present study, E16 rats were used for IUE. After intraventricular injection of the nucleic acids into the embryos, positioning of the tweezer electrodes was critical for targeting either the developing cortex or the hippocampus. Ventricular co-injection and electroporation of a luciferase gene allowed monitoring of the transfected cells postnatally after intraperitoneal luciferin injection in the anesthetized live P7 pup by in vivo bioluminescence, using an IVIS Spectrum device with 3D quantification software. Area definition by bioluminescence could clearly differentiate between cortical and hippocampal electroporations and detect a signal longitudinally over time up to 5 weeks after birth. This imaging technique allowed us to select pups with a sufficient number of transfected cells assumed necessary for triggering biological effects and, subsequently, to perform behavioral investigations at 3 month of age. As an example, this study demonstrates that IUE with the human full length DISC1 gene into the rat cortex led to amphetamine hypersensitivity. Co-transfected GFP could be detected in neurons by post mortem fluorescence microscopy in cryosections indicating gene expression present at ≥6 months after birth. We conclude that postnatal bioluminescence imaging allows evaluating the success of transient transfections with IUE in rats. Investigations on the influence of topical gene manipulations during neurodevelopment on the adult brain and its connectivity are greatly facilitated. For many scientific questions, this technique can supplement or even replace the use of transgenic rats and provide a novel technology for behavioral neuroscience.


Subject(s)
Cerebral Cortex/physiology , Electroporation/methods , Hippocampus/physiology , Luminescent Measurements/methods , Transfection/methods , Animals , Cerebral Cortex/embryology , DNA/administration & dosage , DNA/genetics , Embryo, Mammalian , Female , Hippocampus/embryology , Injections, Intraventricular , Luciferases/biosynthesis , Luciferases/chemistry , Luciferases/genetics , Pregnancy , Rats , Rats, Transgenic
2.
Neurosci Biobehav Rev ; 37(9 Pt A): 2059-70, 2013 Nov.
Article in English | MEDLINE | ID: mdl-23466533

ABSTRACT

The absence or loss of rewards or reinforcers holds a major role in the development of depression in humans. In spite of the prevalence of extinction-induced depression (EID) in humans, few attempts have been made to establish animal models thereof. Here we present the concept of extinction-related depression and summarize the results of two sets of studies in our attempt to create animal models of EID, one set based on extinction after positive reinforcement in the Skinner-box, the other on extinction after negative reinforcement - escape from water. We found various behaviors emitted during the extinction trials that responded to treatment with antidepressant drugs: Accordingly, the important behavioral marker for EID during extinction of escape from the water was immobility. During extinction after positive reinforcement the important indices for extinction-induced depression are the withdrawal from the former site of reward, biting behavior and rearing up on the hind legs. Avoidance behavior and biting may model aspects of human depressive behavior, which may include withdrawal or avoidance as well as aggressive-like behaviors.


Subject(s)
Antidepressive Agents/pharmacology , Depression/drug therapy , Extinction, Psychological/drug effects , Reward , Animals , Behavior, Animal , Depression/chemically induced , Disease Models, Animal , Humans , Reinforcement, Psychology
3.
Trends Pharmacol Sci ; 34(3): 162-6, 2013 Mar.
Article in English | MEDLINE | ID: mdl-23384389

ABSTRACT

Conditioned place preference (CPP) is a learned behavior shown in many vertebrates, including humans. CPP occurs when a subject comes to prefer one place more than others because the preferred location has been paired previously with rewarding events. The CPP paradigm is widely used to explore the reinforcing effects of natural and pharmacological stimuli, including drugs of addiction. There is a general assumption that an acquired place preference is based on classical conditioning derived 'incentive motivation'. However, this may be an oversimplification of the multiple learning processes involved. We argue that although CPP may appear as an incentive-driven behavior related to secondary reinforcers, it may also be a result of operant conditioning of behavior prevailing at the conditioning site, as well as a result of conditioned treatment effects. Here, we outline alternative explanations for an observed CPP, which may fundamentally affect the interpretation of results with this paradigm in its use as a screening tool for rewarding properties of treatments.


Subject(s)
Conditioning, Classical , Animals , Humans
4.
Addict Biol ; 18(3): 452-4, 2013 May.
Article in English | MEDLINE | ID: mdl-22070124

ABSTRACT

Epigenetic processes have been implicated in neuronal plasticity following repeated cocaine application. Here we measured DNA methylation at promoter CpG sites of the dopamine transporter (DAT1) and serotonin transporter (SERT) and neurokinin3-receptor (NK3-R)-receptor (TACR3) coding genes in marmoset monkeys after repeated cocaine injections in a conditioned place preference paradigm. We found a decrease in DNA methylation at a specific CpG site in TACR3, but not DAT1 or SERT. Thus, TACR3 is a locus for DNA methylation changes in response to repeated cocaine administration and its establishment as a reinforcer, in support of other evidence implicating the NK3-R in reinforcement- and addiction-related processes.


Subject(s)
Cocaine/pharmacology , Dopamine Plasma Membrane Transport Proteins/metabolism , Dopamine Uptake Inhibitors/pharmacology , Receptors, Neurokinin-3/genetics , Reinforcement, Psychology , Serotonin Plasma Membrane Transport Proteins/metabolism , Animals , Callithrix , Cocaine-Related Disorders/genetics , Conditioning, Operant/drug effects , Methylation/drug effects , Receptors, Neurokinin-3/metabolism
5.
Hippocampus ; 22(5): 1058-67, 2012 May.
Article in English | MEDLINE | ID: mdl-20882546

ABSTRACT

The neurokinin receptors (NK-R), NK(2)- and NK(3)-R, have been implicated in behavioral processes, but apparently in opposite ways: while NK(2)-R agonism disrupts memory and has anxiogenic-like action, NK(3) -R agonists facilitate memory and display anxiolytic-like effects. Systemic application of NK(2)-R antagonists block the release of acetylcholine (ACh) in the hippocampus, which is induced by intraseptal administration of the NK(2)-R ligand, neurokinin A (NKA). We investigated the effects of medial septal injection of NKA and a preferred ligand of NK(3)-R, neurokinin B (NKB), on the activity of cholinergic neurons of the basal forebrain and assessed the role of the medial septal NK(2)-R in the control of extracellular ACh levels in cholinergic projection areas. ACh was dialysed in the frontal cortex, amygdala and hippocampus of anesthetized animals and was analysed by HPLC-EC. ACh levels in hippocampus and amygdala, but not in frontal cortex were increased after intraseptal injection of either NKA or NKB (0.1, 1, 10 µM). Application of the nonpeptidic NK(2)-R antagonist, saredutant SR48968 (1, 10, 100 pM), followed by NKA (1 µM) or NKB (10 µM) injection into the medial septum, blocked the ACh increase in hippocampus and amygdala. These results indicate that medial septal NK(2)-R have an important role in mediating ACh release, for one, via the septal-hippocampal cholinergic projection and, secondly, via direct or indirect route to the amygdala, but not frontal cortex. They also support the hypothesis that hippocampal cholinergic neurotransmission controls amygdala function suggesting that this interaction is regulated via NK(2)-R in the medial septum.


Subject(s)
Acetylcholine/metabolism , Amygdala/metabolism , Hippocampus/metabolism , Neurokinin A/metabolism , Neurokinin B/metabolism , Receptors, Neurokinin-2/metabolism , Analysis of Variance , Animals , Benzamides/pharmacology , Cholinergic Neurons/drug effects , Cholinergic Neurons/metabolism , Frontal Lobe/metabolism , Male , Memory/drug effects , Neurokinin A/administration & dosage , Neurokinin B/administration & dosage , Piperidines/pharmacology , Rats , Rats, Wistar , Receptors, Neurokinin-2/agonists , Receptors, Neurokinin-2/antagonists & inhibitors , Receptors, Neurokinin-3/agonists , Receptors, Neurokinin-3/antagonists & inhibitors , Receptors, Neurokinin-3/metabolism , Septal Nuclei/metabolism , Septum of Brain/metabolism
6.
J Neurochem ; 119(3): 419-46, 2011 Nov.
Article in English | MEDLINE | ID: mdl-21883214

ABSTRACT

Anesthesia describes a complex state composed of immobility, amnesia, hypnosis (sleep or loss of consciousness), analgesia, and muscle relaxation. Bottom-up approaches explain anesthesia by an interaction of the anesthetic with receptor proteins in the brain, whereas top-down approaches consider predominantly cortical and thalamic network activity and connectivity. Both approaches have a number of explanatory gaps and as yet no unifying view has emerged. In addition to a direct interaction with primary target receptor proteins, general anesthetics have massive effects on neurotransmitter activity in the brain. They can change basal transmitter levels by interacting with neuronal activity, transmitter synthesis, release, reuptake and metabolism. By that way, they can affect a great number of neurotransmitter systems and receptors. Here, we review how different general anesthetics affect extracellular activity of neurotransmitters in the brain during induction, maintenance, and emergence from anesthesia and which functional consequences this may have. Commonalities and differences between different groups of anesthetics in their action on neurotransmitter activity are discussed. We also review how general anesthetics affect the response dynamics of the neurotransmitter systems after sensory stimulation. More than 30 years of research have now yielded a complex picture of the effects of general anesthetics on brain neurotransmitter basal activity and response dynamics. It is suggested that analyzing the effects on neurotransmitter activity is the logical next step after protein interactions in a bottom-up analysis of anesthetic action in the brain on the way to a unifying view of anesthesia.


Subject(s)
Anesthesia, General/methods , Brain Chemistry/physiology , Neurons/physiology , Neurotransmitter Agents/physiology , Animals , Consciousness/physiology , Humans , Neurons/metabolism , Neurotransmitter Agents/metabolism , Protein Binding/physiology
7.
Brain Res Bull ; 84(3): 229-34, 2011 Feb 28.
Article in English | MEDLINE | ID: mdl-21236320

ABSTRACT

Cocaine is a major stimulant drug which can have rewarding and locomotor activating effects. It is used by non-addicts to enhance concentration and performance in a work or social setting. It was suggested that cocaine may amplify the impact of mood and sensory stimulation on behaviour. Here we tested whether cocaine can enhance the impact of novel sensory stimulation on exploratory locomotor activity. In this study the effects of cocaine (0, 2.5, 5.0, 10mg/kg, i.p.) on the locomotor response induced by on-off light stimulation with different light intensities (0, 22, 83, 440 lx) was investigated. Visual stimulation increased locomotor activity and grooming behaviour. Cocaine more dramatically increased locomotion and rearing behaviour but suppressed grooming. Also, visual stimulation effects on grooming were reduced by cocaine. The additive relationship between the cocaine and visual stimulation effects on locomotion and rearing combined with their opposing impact upon grooming point to independent mechanisms mediating cocaine- and visual stimulation-induced behavioural activation.


Subject(s)
Behavior, Animal/drug effects , Cocaine/pharmacology , Dopamine Uptake Inhibitors/pharmacology , Light , Affect/drug effects , Affect/physiology , Animals , Behavior, Animal/physiology , Grooming/drug effects , Grooming/physiology , Male , Motor Activity/drug effects , Motor Activity/physiology , Photic Stimulation , Rats , Rats, Wistar
8.
Rev Neurosci ; 19(2-3): 101-11, 2008.
Article in English | MEDLINE | ID: mdl-18751518

ABSTRACT

Neurokinin3 (NK3) receptors and their endogenous ligands (e.g. the neuropeptide substance P and its C-terminal fragment) have been implicated in psychomotor activity and reinforcement mechanisms. We review here recent findings on the involvement of NK3 receptors in the behavioral and neurochemical effects of cocaine. Although NK3 receptors can modulate dopamine (DA) activity in the brain, recent results suggest that this modulation does not occur during spontaneous behavioral activity. However, NK3 receptors play a role in the regulation of cocaine-induced DA responses in the nucleus accumbens core and shell subregions. NK3 receptor agonism as well as antagonism potentiate cocaine's effects on nucleus accumbens DA subregions specifically, and modulate the acute behavioral effects of cocaine in rats and non-human primates (Callithrix penicillata). However, conditioned place preference studies in rats have, so far, failed to provide evidence for an involvement of NK3 receptors in the reinforcing effects of cocaine.


Subject(s)
Behavior, Animal/drug effects , Brain Chemistry/drug effects , Cocaine/pharmacology , Dopamine Uptake Inhibitors/pharmacology , Receptors, Neurokinin-3/physiology , Animals , Conditioning, Operant/drug effects , Dopamine/metabolism , Haplorhini , Nucleus Accumbens/drug effects , Nucleus Accumbens/metabolism , Rats , Receptors, Neurokinin-3/agonists
9.
Rev Neurosci ; 15(4): 231-40, 2004.
Article in English | MEDLINE | ID: mdl-15526548

ABSTRACT

The ability to build higher order multi-modal memories comprising information about the spatio-temporal context of events has been termed 'episodic memory'. Deficits in episodic memory are apparent in a number of neuropsychiatric diseases. Unfortunately, the development of animal models of episodic memory has made little progress. Towards the goal of such a model we devised an object exploration task for mice, providing evidence that rodents can associate object, spatial and temporal information. In our task the mice learned the temporal sequence by which identical objects were introduced into two different contexts. The 'what' component of an episodic memory was operationalized via physically distinct objects; the 'where' component through physically different contexts, and, most importantly, the 'when' component via the context-specific inverted sequence in which four objects were presented. Our results suggest that mice are able to recollect the inverted temporal sequence in which identical objects were introduced into two distinct environments. During two consecutive test trials mice showed an inverse context-specific exploration pattern regarding identical objects that were previously encountered with even frequencies. It seems that the contexts served as discriminative stimuli signaling which of the two sequences are decisive during the two test trials.


Subject(s)
Memory/physiology , Pattern Recognition, Visual/physiology , Space Perception/physiology , Analysis of Variance , Animals , Behavior, Animal , Cues , Exploratory Behavior/physiology , Male , Mice , Mice, Inbred C57BL , Neuropsychological Tests , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL